1. Home
  2. ON vs TEVA Comparison

ON vs TEVA Comparison

Compare ON & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON Semiconductor Corporation

ON

ON Semiconductor Corporation

HOLD

Current Price

$85.21

Market Cap

31.4B

Sector

Technology

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$32.03

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ON
TEVA
Founded
1992
1901
Country
United States
Israel
Employees
N/A
32842
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
33.5B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ON
TEVA
Price
$85.21
$32.03
Analyst Decision
Buy
Strong Buy
Analyst Count
25
8
Target Price
$65.29
$38.63
AVG Volume (30 Days)
7.6M
4.6M
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$5,878,300,000.00
N/A
Revenue This Year
$7.93
N/A
Revenue Next Year
$8.90
$2.97
P/E Ratio
$286.72
$28.19
Revenue Growth
N/A
N/A
52 Week Low
$37.19
$13.61
52 Week High
$83.52
$37.35

Technical Indicators

Market Signals
Indicator
ON
TEVA
Relative Strength Index (RSI) 82.47 58.60
Support Level $53.64 $30.70
Resistance Level N/A $33.42
Average True Range (ATR) 2.78 0.90
MACD 2.32 0.35
Stochastic Oscillator 99.44 84.63

Price Performance

Historical Comparison
ON
TEVA

About ON ON Semiconductor Corporation

Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: